Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$834M |
| 2 |
FedEx
FDX
|
+$666M |
| 3 |
Microsoft
MSFT
|
+$594M |
| 4 |
Advanced Micro Devices
AMD
|
+$585M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.17B |
| 2 |
Amazon
AMZN
|
+$1.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Wells Fargo
WFC
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.63% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 1.29% |
| 4 | Communication Services | 0.93% |
| 5 | Healthcare | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Celldex Therapeutics
CLDX
$3.07B
| $8.31M | ﹤0.01% |
153,960
+47,512
| +45% | +$2.23M |
|
3102
CALL
Fluor
FLR
$7.12B
| $8.3M | ﹤0.01% |
519,700
-118,300
| -19% | -$1.94M |
|
3103
PUT
Invesco
IVZ
$14.5B
| $8.3M | ﹤0.01% |
344,100
-53,500
| -13% | -$1.34M |
|
3104
PUT
TaskUs
TASK
$769M
| $8.29M | ﹤0.01% |
+124,900
| New | +$5.92M |
|
|
LAZR
3105
DELISTED
Luminar Technologies
LAZR
| $8.29M | ﹤0.01% |
35,421
+32,291
| +1,032% | +$8.55M |
|
3106
CALL
SelectQuote
SLQT
$91.8M
| $8.28M | ﹤0.01% |
640,300
+258,800
| +68% | +$3.9M |
|
3107
Kodiak Sciences
KOD
$2.37B
| $8.27M | ﹤0.01% |
86,142
+19,759
| +30% | +$1.83M |
|
3108
PUT
Brookfield
BN
$92.3B
| $8.27M | ﹤0.01% |
286,675
+154,007
| +116% | +$4.5M |
|
3109
PUT
iShares Russell 1000 ETF
IWB
$49.1B
| $8.27M | ﹤0.01% |
34,200
+27,300
| +396% | +$6.79M |
|
3110
PUT
Sphere Entertainment
SPHR
$5.09B
| $8.26M | ﹤0.01% |
113,700
+28,000
| +33% | +$2.1M |
|
3111
Marriott International
MAR
$91.5B
| $8.26M | ﹤0.01% |
55,750
-656,441
| -92% | -$91.6M |
|
3112
CALL
Children's Place
PLCE
$54.9M
| $8.26M | ﹤0.01% |
109,700
-58,700
| -35% | -$5.2M |
|
3113
CALL
Universal Health Services
UHS
$10.1B
| $8.25M | ﹤0.01% |
59,600
-30,700
| -34% | -$4.65M |
|
|
HBI
3114
PUT
DELISTED
Hanesbrands
HBI
| $8.24M | ﹤0.01% |
480,400
+131,700
| +38% | +$2.47M |
|
3115
Cemex
CX
$15.7B
| $8.22M | ﹤0.01% |
1,147,171
+454,521
| +66% | +$3.59M |
|
3116
PUT
Inspire Medical Systems
INSP
$1.78B
| $8.22M | ﹤0.01% |
35,300
-1,100
| -3% | -$230K |
|
3117
CALL
iShares MSCI United Kingdom ETF
EWU
$3.81B
| $8.22M | ﹤0.01% |
254,800
+129,700
| +104% | +$4.26M |
|
|
SNV
3118
CALL
DELISTED
Synovus
SNV
| $8.21M | ﹤0.01% |
187,100
+52,900
| +39% | +$2.24M |
|
|
CCXI
3119
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
| $8.21M | ﹤0.01% |
480,100
+132,900
| +38% | +$2.07M |
|
3120
CALL
Spectrum Brands
SPB
$2.04B
| $8.21M | ﹤0.01% |
85,800
+45,700
| +114% | +$3.88M |
|
|
ACH
3121
PUT
Accendra Health
ACH
$93.1M
| $8.2M | ﹤0.01% |
262,100
+128,700
| +96% | +$5.07M |
|
|
ITCI
3122
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $8.19M | ﹤0.01% |
219,800
+79,400
| +57% | +$2.76M |
|
|
CEQP
3123
CALL
DELISTED
Crestwood Equity Partners LP
CEQP
| $8.19M | ﹤0.01% |
288,700
-98,900
| -26% | -$2.75M |
|
3124
Stanley Black & Decker
SWK
$14.8B
| $8.19M | ﹤0.01% |
46,714
+16,497
| +55% | +$3.22M |
|
3125
PUT
Organon & Co
OGN
$3.61B
| $8.19M | ﹤0.01% |
249,700
+165,400
| +196% | +$5.29M |
|
Similar funds
Jeff Yass's Q3 2021 Portfolio in Review
As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
- Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
- Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
- Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
- Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
- Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
- Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.